Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LeMaitre Vascular Q4 2023 GAAP EPS $0.38 Beats $0.36 Estimate, Sales $48.88M Miss $49.02M Estimate

Author: Benzinga Newsdesk | February 27, 2024 05:42pm
LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.36 by 5.56 percent. The company reported quarterly sales of $48.88 million which missed the analyst consensus estimate of $49.02 million by 0.28 percent. This is a 19.36 percent increase over sales of $40.95 million the same period last year.

Posted In: LMAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist